Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation

NCT03792620 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma Stage I

Interventions

COMBINATION_PRODUCT: Cyclo Thal Dex Daratumumab

Sponsor

Grupo de Estudos Multicentricos em Onco-Hematologia